Select a medication above to begin.
Cabometyx
cabozantinib
Adult Dosing .
Dosage forms: TAB: 20 mg, 40 mg, 60 mg
Special Note
- [formulation clarification]
- Info: not interchangeable w/ cabozantinib capsules; do not substitute on a mg to mg basis
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing incl. toxicity-related dose adjustments; D/C >3wk before elective surgery or invasive dental procedure, restart >2wk after major surgery when wound fully healed
renal cell CA, advanced
- [previously treated dz, monotherapy]
- Dose: 60 mg PO qd; Info: for pts who had received at least 1 prior anti-angiogenic tx; give at least 1h before or 2h after meals; do not cut/crush/chew tab
- [first-line tx, combo w/ nivolumab]
- Dose: 40 mg PO qd; Info: give at least 1h before or 2h after meals; do not cut/crush/chew tab
hepatocellular CA, previously treated
- [60 mg PO qd]
- Info: for pts who have received sorafenib; give at least 1h before or 2h after meals; do not cut/crush/chew tab
differentiated thyroid CA, locally advanced or metastatic
- [60 mg PO qd]
- Info: for pts w/ progressive dz after VEGFR-targeted tx, and who are radioactive iodine-refractory or ineligible; give at least 1h before or 2h after meals; do not cut/crush/chew tab
neuroendocrine tumors, unresectable locally advanced or metastatic
- [60 mg PO qd]
- Info: for previously treated, well-differentiated pancreatic or extra-pancreatic dz; give at least 1h before or 2h after meals; do not cut/crush/chew tab
renal dosing
- [see below]
- eGFR >30: no adjustment; eGFR <30: not defined
- HD/PD: not defined
hepatic dosing
- [see below]
- Child-Pugh Class B: decr. usual start dose by 20 mg; Child-Pugh Class C: avoid use
Peds Dosing .
- Dosage forms: TAB: 20 mg, 40 mg, 60 mg
Special Note
- [formulation clarification]
- Info: not interchangeable w/ cabozantinib capsules; do not substitute on a mg to mg basis
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing incl. toxicity-related dose adjustments; D/C >3wk before elective surgery or invasive dental procedure, restart >2wk after major surgery when wound fully healed
differentiated thyroid CA, locally advanced or metastatic
- [12 yo and older, <40 kg]
- Dose: 40 mg PO qd; Info: for pts w/ progressive dz after VEGFR-targeted tx, and who are radioactive iodine-refractory or ineligible; give at least 1h before or 2h after meals; do not cut/crush/chew tab
- [12 yo and older, >40 kg]
- Dose: 60 mg PO qd; Info: for pts w/ progressive dz after VEGFR-targeted tx, and who are radioactive iodine-refractory or ineligible; give at least 1h before or 2h after meals; do not cut/crush/chew tab
neuroendocrine tumors, unresectable locally advanced or metastatic
- [12 yo and older, <40 kg]
- Dose: 40 mg PO qd; Info: for previously treated, well-differentiated pancreatic or extra-pancreatic dz; give at least 1h before or 2h after meals; do not cut/crush/chew tab
- [12 yo and older, >40 kg]
- Dose: 60 mg PO qd; Info: for previously treated, well-differentiated pancreatic or extra-pancreatic dz; give at least 1h before or 2h after meals; do not cut/crush/chew tab
renal dosing
- [see below]
- eGFR >30: no adjustment; eGFR <30: not defined
- HD/PD: not defined
hepatic dosing
- [see below]
- Child-Pugh Class B: decr. usual dose by 20 mg; Child-Pugh Class C: avoid use